Colgate-Palmolive (India) (500830) Stock Overview
Manufactures and trades in personal and oral care products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
500830 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Colgate-Palmolive (India) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,166.05 |
| 52 Week High | ₹2,505.00 |
| 52 Week Low | ₹1,781.60 |
| Beta | 0.51 |
| 1 Month Change | 8.37% |
| 3 Month Change | 3.31% |
| 1 Year Change | -3.20% |
| 3 Year Change | 8.81% |
| 5 Year Change | 29.94% |
| Change since IPO | 2,254.40% |
Recent News & Updates
Narrative Update • Jun 23
500830: Beauty-Led Oral Care Focus Will Support Attractive Outlook Into 2026
Analysts have made a small trim to their fair value estimate for Colgate-Palmolive (India), nudging the target from about ₹2,263.70 to roughly ₹2,254.62 as they factor in slightly higher discount rates, marginally softer revenue growth assumptions, and a modestly lower profit margin, partly offset by a steady view on future P/E levels. What's in the News Colgate-Palmolive (India) has scheduled a Board Meeting for May 22, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026.Narrative Update • Jun 07
500830: Beauty-Led Oral Care Focus Will Support Stronger Outlook Into 2026
Analysts have lifted their fair value estimate for Colgate-Palmolive (India) from about ₹2,154 to roughly ₹2,264, citing updated assumptions for revenue growth, profit margin and future P/E as key inputs behind the higher price target. What's in the News A board meeting of Colgate-Palmolive (India) is scheduled for May 22, 2026, to approve and record the audited financial results for the quarter and year ended March 31, 2026.Recent updates
Narrative Update • Jun 23
500830: Beauty-Led Oral Care Focus Will Support Attractive Outlook Into 2026
Analysts have made a small trim to their fair value estimate for Colgate-Palmolive (India), nudging the target from about ₹2,263.70 to roughly ₹2,254.62 as they factor in slightly higher discount rates, marginally softer revenue growth assumptions, and a modestly lower profit margin, partly offset by a steady view on future P/E levels. What's in the News Colgate-Palmolive (India) has scheduled a Board Meeting for May 22, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026.Narrative Update • Jun 07
500830: Beauty-Led Oral Care Focus Will Support Stronger Outlook Into 2026
Analysts have lifted their fair value estimate for Colgate-Palmolive (India) from about ₹2,154 to roughly ₹2,264, citing updated assumptions for revenue growth, profit margin and future P/E as key inputs behind the higher price target. What's in the News A board meeting of Colgate-Palmolive (India) is scheduled for May 22, 2026, to approve and record the audited financial results for the quarter and year ended March 31, 2026.Narrative Update • May 19
500830: Beauty-Led Oral Care Focus Will Support Steady Outlook Into 2026
Analysts have trimmed their fair value estimate for Colgate-Palmolive (India) slightly from about ₹2,158 to roughly ₹2,154, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News A board meeting of Colgate-Palmolive (India) is scheduled for May 22, 2026, to approve and record audited financial results for the quarter ended March 31, 2026 (Key Developments).Narrative Update • Apr 26
500830: Beauty-Led Oral Care Focus Will Sustain Balanced Long-Term Potential
Analysts have slightly adjusted their fair value estimate for Colgate-Palmolive (India) to ₹2,157.64 from ₹2,171.04, reflecting small, offsetting tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions. Valuation Changes The fair value estimate for Colgate-Palmolive (India) stands at ₹2,157.64, slightly lower than the previous ₹2,171.04.Narrative Update • Apr 12
500830: Beauty-Led Oral Care Focus Will Support Attractive Future Potential
Analysts have trimmed their price target for Colgate-Palmolive (India) from ₹2,250.32 to ₹2,171.04, reflecting updated assumptions around a slightly higher discount rate, more moderate revenue growth, a marginally stronger profit margin, and a small adjustment to future P/E expectations. What's in the News Colgate-Palmolive (India) has scheduled a board meeting on January 29, 2026, at 16:45 Indian Standard Time.Narrative Update • Mar 27
500830: Beauty-Led Oral Care Focus Will Support Attractive Future Potential
Analysts have made a slight downward revision to their fair value estimate for Colgate-Palmolive (India), trimming the price target by about ₹6 to roughly ₹2,250 as they fine tune assumptions around the discount rate, profit margin, and forward P/E multiples. What's in the News Board meeting scheduled on January 29, 2026, at 16:45 Indian Standard Time to review and approve the unaudited financial results for the third quarter and nine months ended December 31, 2025 (company filing).Narrative Update • Mar 12
500830: Beauty-Led Oral Care Focus Will Support Attractive Future Potential
Analysts have kept their fair value estimate for Colgate-Palmolive (India) broadly unchanged at ₹2,256.57, with a slightly lower discount rate and marginally adjusted long term revenue growth, profit margin and forward P/E assumptions shaping this refreshed price target view. What's in the News A board meeting is scheduled for Jan 29, 2026 at 16:45 Indian Standard Time to consider and approve the unaudited financial results for the third quarter and nine months ended Dec 31, 2025 (Key Developments).Narrative Update • Feb 25
500830: Beauty-Led Oral Care Focus Will Support Steady Future Potential
Analysts have slightly trimmed their fair value estimate for Colgate-Palmolive (India) to ₹2,256 from about ₹2,271, reflecting a modest adjustment to the price target in line with a marginally higher discount rate and broadly unchanged assumptions for revenue growth, profit margin, and future P/E. What's in the News The board of Colgate-Palmolive (India) has scheduled a meeting on January 29, 2026, at 16:45 Indian Standard Time to review and approve the unaudited financial results for the third quarter ended December 31, 2025 (Key Developments).Narrative Update • Feb 11
500830: Beauty-Led Oral Care And Governance Changes Will Support Steady Future Potential
The analyst price target for Colgate-Palmolive (India) has been revised from about ₹2,392 to around ₹2,271, as analysts factor in slightly different assumptions for discount rate, revenue growth, profit margin and future P/E, leading to a modest recalibration of their valuation views. What's in the News A board meeting is scheduled on Jan 29, 2026, at 16:45 IST to approve and record unaudited financial results for the third quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Jan 27
500830: Beauty-Led Oral Care Extensions And Governance Updates Will Support Steady Future Potential
Analysts have trimmed their fair value estimate for Colgate-Palmolive (India) from ₹2,411.57 to ₹2,392.27. This reflects slightly softer assumptions around revenue growth, profit margins and future P/E multiples in their updated models.Narrative Update • Jan 12
500830: New Beauty-Led Oral Care Extensions Will Support Future Upside Potential
Narrative Update on Colgate-Palmolive (India) Analysts have trimmed their price target on Colgate-Palmolive (India) slightly, from ₹2,425.07 to ₹2,411.57. This reflects marginal tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E.Narrative Update • Dec 21
500830: New Beauty-Led Oral And Body Care Portfolio Will Drive Upside
Analysts have increased their price target for Colgate Palmolive India by 0.0 percent to ₹2,425.07, citing slightly lower discount rate assumptions and marginal tweaks to long term growth and profitability expectations. What's in the News Board meeting scheduled on November 26, 2025 to approve the appointment of Mr. Priyan Pillay as Executive Vice President, Legal, and Mr. Jaikishan Shah as Company Secretary and Compliance Officer (Board Meeting) Launch of Colgate Visible White Purple Serum, a color-correcting whitening booster using purple pigments to neutralise yellow tones and brighten smiles, positioned as a beauty plus oral care add-on for everyday and on-the-go use (Product Related Announcement) Board meeting on October 23, 2025 to approve unaudited financial results for Q2 and H1 FY2025 and to consider declaration of an interim dividend, if any (Board Meeting) Palmolive Moments Body Wash range introduced with Mindful Awake, Workout Fresh, and Restful Sleep variants, featuring natural extracts, long-lasting fragrance technologies, and pH-balanced, paraben- and silicone-free formulations, rolling out across major online platforms (Product Related Announcement) Valuation Changes Fair Value: Unchanged at approximately ₹2,425.07 per share, indicating a stable assessment of intrinsic value.Narrative Update • Dec 07
500830: New Oral Care And Body Wash Launches Will Drive Future Upside
Analysts have made a marginal trim to their price target on Colgate Palmolive India, reducing fair value by about ₹3 to approximately ₹2,425. Slightly higher discount rate assumptions and marginally softer long term growth and profitability expectations offset a modestly higher future P E multiple.Narrative Update • Nov 22
500830: New Product Launches And Margin Stability Will Drive Future Uptrend
Analysts have slightly reduced their price target for Colgate-Palmolive (India) from ₹2,434 to ₹2,428. This reflects modest adjustments in their valuation assumptions and expectations for profit margins.Narrative Update • Nov 07
500830: Revenue Expansion Will Sustain Uptrend Despite Slight Profit Margin Dip
Analysts have revised their price target for Colgate-Palmolive (India) downward from ₹2,476.07 to ₹2,433.97, citing slightly reduced projections for revenue growth and profit margin. What's in the News Colgate-Palmolive (India) introduced the Colgate Visible White Purple Serum, a whitening booster that uses purple pigments for color correction and an instantly brighter smile.Narrative Update • Oct 24
Premium Offerings and Expanding Margins Will Shape Future Demand Trends
Analysts have revised their fair value estimate for Colgate-Palmolive (India) downward from ₹2,518.81 to ₹2,476.07, citing updated expectations for lower discount rates as well as slightly improved revenue growth and profit margins. What's in the News The Board of Colgate-Palmolive (India) Limited will meet on October 23, 2025, to review and approve unaudited financial results for the second quarter and half year ended September 30, 2025, and consider the declaration of an interim dividend, if any.Narrative Update • Sep 05
Increasing Indian Incomes Will Drive Premium Oral Care Demand
Both the discount rate and future P/E for Colgate-Palmolive (India) saw only marginal changes, resulting in no meaningful revision to the consensus analyst price target, which remains at ₹2519. What's in the News Board meeting scheduled to approve and record unaudited financial results for the first quarter ended June 30, 2025.New Narrative • Jun 01
Increasing Indian Incomes Will Drive Premium Oral Care Demand
Expansion into premium products and rural markets, along with growing health awareness, is driving sustained revenue growth and broader market penetration.Shareholder Returns
| 500830 | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | 2.8% | -2.6% | -1.1% |
| 1Y | -3.2% | -13.1% | 0.6% |
Return vs Industry: 500830 exceeded the Indian Personal Products industry which returned -13.1% over the past year.
Return vs Market: 500830 underperformed the Indian Market which returned 0.6% over the past year.
Price Volatility
| 500830 volatility | |
|---|---|
| 500830 Average Weekly Movement | 3.4% |
| Personal Products Industry Average Movement | 5.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.7% |
Stable Share Price: 500830 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500830's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 2,276 | Prabha Narasimhan | www.colgatepalmolive.co.in |
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, serum, rinses, whitening products, hand washes, and shower gels under the Colgate and Palmolive brand name. It also offers soaps, cosmetics, and toiletries.
Colgate-Palmolive (India) Limited Fundamentals Summary
| 500830 fundamental statistics | |
|---|---|
| Market cap | ₹589.13b |
| Earnings (TTM) | ₹13.25b |
| Revenue (TTM) | ₹60.35b |
44.5x
P/E Ratio9.8x
P/S RatioIs 500830 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500830 income statement (TTM) | |
|---|---|
| Revenue | ₹60.35b |
| Cost of Revenue | ₹18.92b |
| Gross Profit | ₹41.43b |
| Other Expenses | ₹28.18b |
| Earnings | ₹13.25b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 48.73 |
| Gross Margin | 68.66% |
| Net Profit Margin | 21.96% |
| Debt/Equity Ratio | 0% |
How did 500830 perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield99%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/29 17:00 |
| End of Day Share Price | 2026/07/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Colgate-Palmolive (India) Limited is covered by 52 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Aniruddha Joshi | Anand Rathi Shares and Stock Brokers Limited |